Efruxifermin Shows Fibrosis Reduction in MASH Cirrhosis Cystic Fibrosis & Amyloidosis Orphan Drugs Get European Yes Could This Child Have Spinal Muscular Atrophy?

Read about Akero Therapeutics Inc (AKRO:XNAS) stock and today's latest news and financial updates.

Although the SYMMETRY Phase IIb trial of the FGF21 analogue efruxifermin did not meet its primary endpoint at 36 weeks, ...

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update DA-1241 in Combination with Efruxifermin Shows Enhanced ...

The liver fibrosis market is entering a transformative phase, driven by greater awareness, improved diagnostic ...

Stocktwits - Shares of Akero Therapeutics, Inc. (AKRO) jumped 3% on Friday afternoon after Jefferies said the company has a “promising” takeover potential. Jefferies named South San Francisco-based ...

Shares of Akero Therapeutics, Inc. (AKRO) jumped 3% on Friday afternoon after Jefferies said the company has a “promising” takeover potential. Jefferies thinks big pharma companies are "still on the ...

The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth factor 21, or FGF21, which is an endogenously expressed hormone that protects against cellular stress and ...

TAINAN, Taiwan I June 12, 2025 I Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer’s ...

NEW YORK (AP) — ABC News has suspended correspondent Terry Moran for calling Trump administration deputy chief of staff Stephen Miller a “world class hater” in a since-deleted social media ...

Efruxifermin is a bivalent analogue of fibroblast growth factor 21 (FGF21), a hormone involved in regulating metabolism, and has previously shown promise in improving liver fibrosis in earlier-stage ...